Cyclin-dependent kinase 16 (CDK16) regulates cell differentiation in physiological state while favoring tumor development in pathological state, and can be used as a marker for the prognostic situation of CRC (Guan L et al., 2022). This evidence concerns the gene CDK16 and colorectal carcinoma.